according to Ireland has become a favorable location for pharmaceutical companies in part because of its low corporate tax rate.
And there’s very little bidding on drugs,” Trump said during the news conference in New York earlier this month.
President Trump met with leaders of some of the world’s biggest pharmaceutical companies Tuesday and emphasized the need to lower “astronomical” drug prices, decrease regulations and bring more drug manufacturing into the United States.
Most of Tuesday’s meeting was held behind closed doors, but Trump spoke to the media beforehand while surrounded by executives from a half-dozen large drug companies.
In an afternoon news conference, White House press secretary Sean Spicer said Trump believes that allowing the federal government to negotiate with drug companies for Medicare would push prices lower — a policy that drug companies have opposed.
as mentioned in
Trump pledges to work with Big Pharma to lower drug prices
We have to make products … We have to get rid of a tremendous number of regulations,” Trump said.
“We have no choice,” the President added, sitting at a table surrounded by aides, Vice President Mike Pence and eight pharmaceutical executives.
“For Medicare, for Medicaid, we have to get prices way down, so that’s what we’re going to be talking about.
In a “pharma” meeting in the Oval Office, the President told executives from companies such as Merck & Co. and Johnson & Johnson that they have done a “terrific job over the years” but that prices for drugs must come down.
Story highlights Trump met with eight pharmaceutical company executives at the White House”We have no choice” but to limit regulations, the President saidWashington (CNN) President Donald Trump issued a message Tuesday to pharmaceutical company executives akin to one he delivered to auto executives last week: bring your production back to the United States and the Trump administration will lower regulations for you.
as mentioned in And liberals, led by politicians like Vermont Sen. Bernie Sanders, champion a robust government role to keep drug prices down.
Like Mr. Ryan, Mr. Price is a small-government conservative skeptical of such interventions.
In a Kaiser Foundation poll last autumn, the public, by 82 percent to 17 percent, favored allowing the federal government to negotiate lower drug prices.
Huge majorities say costly drug prices — in recent years they have risen about four times the rate of inflation — are a major concern.
He vows to keep a campaign pledge to push legislation allowing Medicare to negotiate prescription drug prices, a practice now prohibited by law.
about the details read more from here
This content may collect you by Jack Oliver